^
    Apply
    Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer (NCT05744687)
    Phase 2/3
    Shanghai Pharmaceuticals Holding Co., Ltd
    Recruiting
    Last update posted :
    05/24/2024
    Initiation :
    04/24/2023
    Primary completion :
    08/18/2024
    Completion :
    12/16/2024
    HER-2
    |
    HR positive • HER-2 negative
    |
    letrozole • SPH4336